Pricing Log in Create free account

Disc Medicine, Inc. (IRON) vs Tango Therapeutics, Inc. (TNGX)

Disc Medicine, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Disc Medicine, Inc. and Tango Therapeutics, Inc. are of similar size ($3.5B and $3.5B). Across the 11 metrics below, Tango Therapeutics, Inc. leads on 10 and Disc Medicine, Inc. on 1.

Valuation

Metric IRON TNGX Biotechnology median
P/E n/m n/m 10.26
P/S n/m 50.96 9.18
P/B 4.74 3.10 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 34.70 8.98
Earnings yield (8.33%) (3.96%) (34.89%)
Free cash flow yield (6.50%) (4.54%) (24.52%)

Profitability

Metric IRON TNGX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.08%) (21.34%) (50.12%)
Return on assets (35.12%) (18.86%) (45.60%)
Return on invested capital 0.00% (808.35%) 0.00%

Growth

Metric IRON TNGX Biotechnology median
Revenue growth (TTM) — 48.29% 6.26%
EPS growth (last fiscal year) (51.77%) 26.89% 29.88%
Revenue growth, 5-year CAGR — 52.13% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRON TNGX Biotechnology median
Debt to equity 0.09 0.00 0.00
Current ratio 24.14 50.82 4.89
Net debt to EBITDA 3.12 3.08 1.01

Dividend

Metric IRON TNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IRON TNGX Biotechnology median
Market cap 3.48b 3.52b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack